{"id":10951,"date":"2014-07-08T00:00:00","date_gmt":"2014-07-07T22:00:00","guid":{"rendered":"https:\/\/idibell.cat\/es\/blog\/2014\/07\/08\/la-fundacion-mutua-madrilena-financia-un-proyecto-de-investigacion-de-tratamientos-personalizados-en-cancer-de-pulmon-2\/"},"modified":"2020-05-22T08:44:45","modified_gmt":"2020-05-22T06:44:45","slug":"la-fundacion-mutua-madrilena-financia-un-proyecto-de-investigacion-de-tratamientos-personalizados-en-cancer-de-pulmon-2","status":"publish","type":"post","link":"https:\/\/idibell.cat\/es\/2014\/07\/la-fundacion-mutua-madrilena-financia-un-proyecto-de-investigacion-de-tratamientos-personalizados-en-cancer-de-pulmon-2\/","title":{"rendered":"La Fundaci\u00f3n Mutua Madrile\u00f1a financia un proyecto de investigaci\u00f3n de tratamientos personalizados en c\u00e1ncer de pulm\u00f3n"},"content":{"rendered":"

La Fundaci\u00f3n Mutua Madrile\u00f1a en la XI Convocatoria de Ayudas a la Investigaci\u00f3n, ha seleccionado un proyecto dirigido a la personalizaci\u00f3n del tratamiento del c\u00e1ncer de pulm\u00f3n liderado por el jefe del grupo de quimiorresistencia del ICO-IDIBELL, Alberto Villanueva. La ayuda concedida es de 41.000 euros.
El proyecto se basa en la personalizaci\u00f3n de tratamientos contra el c\u00e1ncer de pulm\u00f3n de c\u00e9lula no peque\u00f1a (NSCLC) a partir de la generaci\u00f3n de modelos de ratones ortot\u00f3picos individualizados u ortoxenografts. Se trata de un proyecto multidisciplinar en el que colaboran investigadores b\u00e1sicos y cl\u00ednicos del ICO, IDIBELL y del Hospital Universitario de Bellvitge.
En la XI edici\u00f3n de sus ayudas a la investigaci\u00f3n, la Fundaci\u00f3n Mutua Madrile\u00f1a, ha aprobado la financiaci\u00f3n de 54 proyectos de investigaci\u00f3n con m\u00e1s de un mill\u00f3n setecientos mil euros .<\/p>\n","protected":false},"excerpt":{"rendered":"

La Fundaci\u00f3n Mutua Madrile\u00f1a en la XI Convocatoria de Ayudas a la Investigaci\u00f3n, ha seleccionado un proyecto dirigido a la personalizaci\u00f3n del tratamiento del c\u00e1ncer de pulm\u00f3n liderado por el jefe del grupo de quimiorresistencia del ICO-IDIBELL, Alberto Villanueva. La ayuda concedida es de 41.000 euros. El proyecto se basa en la personalizaci\u00f3n de tratamientos […]<\/p>\n","protected":false},"author":6,"featured_media":10952,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"no-sidebar","site-content-layout":"page-builder","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[184,281,206],"tags":[],"class_list":["post-10951","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-area-cancer","category-programa-de-mecanismos-moleculares-y-terapia-experimental-en-oncologia-oncobell","category-quimioresistencia-tumoral-y-estromal"],"publishpress_future_action":{"enabled":false,"date":"2024-11-30 04:10:45","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category"},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/posts\/10951","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/comments?post=10951"}],"version-history":[{"count":0,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/posts\/10951\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/media\/10952"}],"wp:attachment":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/media?parent=10951"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/categories?post=10951"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/tags?post=10951"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}